bosentan monohydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
BOSENTAN GH bosentan (as monohydrate) 125 mg film-coated tablets bottle AUST R: 235883Active ingredients:
bosentan monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Generic Health Pty Ltd
Phone:
03 9809 7900
|
From
01 Dec 2023
to
20 Dec 2024
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
Alternative generic product is available.
|
BOSENTAN RBX bosentan (as monohydrate) 62.5 mg film-coated tablet blister pack AUST R: 257757Active ingredients:
bosentan monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Sun Pharma ANZ Pty Ltd
Phone:
0298872600
|
From
27 Jun 2024
to
09 Sep 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
TRACLEER bosentan 125mg (as monohydrate) tablet bottle AUST R: 91920Active ingredients:
bosentan monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800 226 334
|
Deletion from market:
31 Dec 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available. The sponsor will continue to supply to existing eligible patients enrolled in the compassionate supply program until the end of December 2024.
|
TRACLEER bosentan 62.5mg (as monohydrate) tablet bottle AUST R: 91919Active ingredients:
bosentan monohydrate
Dosage form:
Tablet, film coated
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800 226 334
|
Deletion from market:
31 Dec 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available. The sponsor will continue to supply to existing eligible patients enrolled in the compassionate supply program until the end of December 2024.
|